Sod1 inhibitor LCS-1 counteracted the therapeutic effects of Exo/ASO-TNF or Exo/2DG on CDAA-induced NASH in mice. The gene discussed is SOD1; the disease is metabolic dysfunction-associated steatohepatitis.